DLA-Compliant Packaging and Labeling
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The contract requires the packaging and labeling of pharmaceutical products in strict compliance with Defense Logistics Agency standards, ensuring all items are properly marked with mandatory identifiers including the National Stock Number, National Drug Code, CAGE code 1LEZO, and TCN W50YF262160118. This subcontract is tied to the Department of Defense and falls under the NAICS code 325999 for other pharmaceutical and medicine manufacturing, emphasizing precision in adherence to federal labeling protocols for military medical supply chains. The work must be performed in accordance with DLA marking specifications, and while the exact performance location is unspecified, the contract is linked to the official DIBBS award record with contract SPE2DX25D9900 and delivery order SPE2DP26F8714, indicating the procurement was initiated through a government-wide system for defense logistics. The solicitation was posted on August 5, 2026, suggesting this is a forward-looking requirement for future fulfillment.
General Info
Agency
NAICS
Place of Performance
Not specifiedSet-Aside
Documents
This scope was carved out of SPE2DP26F8714.
The full solicitation package (2 documents), including the RFP, is on the prime solicitation, not on this scope.
FEXOFENADINE HYDROCHLORIDE TABLETS
AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
